← All stocks

ASSEMBLY BIOSCIENCES, INC.

ASMB No buying or selling
CIK 0001426800 #2862 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
4.0×

Jason A. Okazaki holds only 4.0 times base salary in stock. $2.60M of shares against $647.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason A. Okazaki last reported holding, valued at $23.25, the price Common Stock was last bought or sold at on the open market here, on 17 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GILEAD SCIENCES, INC. entity
10% owner
4,977,089
$115.72M
+292.2%
Schornstein Alexander
10% owner
728,113
$16.93M
+5.0%
Okazaki Jason A
CEO and President
111,916
$2.60M
Delaney William E IV
Chief Scientific Officer
45,642
$1.06M
+709.0%
White Nicole S
Chief Manufacturing Officer
37,477
$871.34K
Gaggar Anuj
Chief Medical Officer
28,000
$651.00K
McHutchison John G
Director
18,347
$426.57K
−4.0%
Bjorkquist Jeanette M
PFO and PAO
14,560
$338.52K
+363.4%
Houghton Michael
Director
3,202
$74.45K

No percentages here. This company's share count has moved by a factor of 3.2 over the window, from 6,356,286 to 20,360,596 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Mar 2017